MetrioPharm Press Releases
Since MetrioPharm AG was able to finalize the regulatory pharmacology and toxicology studies in the past months, all requirements for clinical studies are now fulfilled.
On March 26. – 30. 2014 over 2000 scientists from around the world met in Nice for the 9th International Congress on Autoimmunity.
The most important outcome was MP1032's superior safety profile as confirmed by the results from the various regulatory pharmacology and toxicology studies conducted throughout the past year.